HealthEdge Investment Partners Invests in Anodyne
April 25, 2022
HealthEdge Investment Partners completed a platform investment in Anodyne, a provider of lifestyle-oriented clinical footwear and custom orthotics most commonly prescribed for diabetic patients. HealthEdge will partner with Anodyne to accelerate growth, expand distribution and scale the company's in-house manufacturing capabilities.
- Buyers
- HealthEdge Investment Partners, LLC
- Targets
- Anodyne, LLC
- Industry
- Medical Devices
- Location
- Wisconsin, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
HealthEdge and Synergistic Capital Partners Invest in Today's Dental Network
July 13, 2021
Dental
HealthEdge Investment Partners and Synergistic Capital Partners completed an investment in Today's Dental Network (TDN), a multi-specialty concierge dental practice network supporting 17 locations across Southwest Florida. The capital and partnership will support TDN’s growth plan to expand via additional partnership and specialty practice acquisitions while providing centralized practice-management services and technology.
-
HealthEdge Invests in Specialty Pharmacy Nursing Network (SPNN)
March 31, 2021
Healthcare Services
HealthEdge Investment Partners, a healthcare-focused private equity firm, completed an investment in Specialty Pharmacy Nursing Network, Inc. (SPNN), a Sarasota-based national provider of specialty home infusion nursing services. SPNN founder Cherylann Gregory remains CEO and the investment will help accelerate SPNN's growth by pairing its clinical nursing network with HealthEdge's industry experience, network, and resources.
-
HealthEdge Acquires Legacy-Xspire Holdings, LLC
December 18, 2019
Pharmaceuticals
HealthEdge Investment Partners, a Tampa-based healthcare-focused private equity firm, completed an acquisition of Legacy-Xspire Holdings, LLC, a Ridgeland, Mississippi-based branded and generic pharmaceutical marketing and distribution platform, on December 18, 2019. The deal adds a pharmaceutical marketing and distribution capability (combining WraSer Pharmaceuticals, Gentex Pharma, and Xpsire Pharma) to HealthEdge's portfolio to support organic growth and product acquisitions across the U.S.
-
Bain Capital to Acquire HealthEdge from Blackstone Funds
April 8, 2025
Cloud & SaaS
Bain Capital's Private Equity team has agreed to acquire HealthEdge, a Burlington, Massachusetts–based healthcare SaaS platform, from funds managed by Blackstone. Financial terms were not disclosed; the transaction is expected to close in Q2 2025 and positions Bain to accelerate HealthEdge's product growth and GenAI enablement for health plans.
-
HealthEdge Partners with P3 Oral Surgery to Build Leading Oral Surgery Platform
December 4, 2023
Healthcare Services
HealthEdge Investment Partners has made a strategic growth investment in Pluri Potent Partnership, LLC (doing business as P3 Oral Surgery), partnering with P3's surgeons who retain a meaningful ownership stake. The capital and support will be used to scale P3's oral and maxillofacial surgery platform across the Mid-Atlantic, pursue new surgeon partnerships, and expand operational capabilities.
-
InTandem Capital Partners Acquires OrthoNebraska
August 3, 2023
Healthcare Services
InTandem Capital Partners completed a strategic equity investment to acquire OrthoNebraska, a regional provider of orthopedic and musculoskeletal care headquartered in Omaha, Nebraska. Audax Private Debt provided a unitranche credit facility to support the transaction; InTandem intends to accelerate OrthoNebraska's growth by expanding clinical capabilities and geographic reach.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.